483 AstraZeneca Pharmaceuticals, LP Jan 2018

483 AstraZeneca Pharmaceuticals, LP Jan 2018

David Chon FDA$119.00 - Available Now

FDA investigators audited the AstraZeneca Pharmaceuticals, LP - Gaithersburg, MD, United States facility and issued inspectional observations (via FDA 483) on 30 Jan 2018.

Product details

  • Category: Human Drugs
  • Inspection end: 30 Jan 2018
  • Location: Gaithersburg, United States
  • FEI: 3007851755
Add To Cart